Sonoma Pharmaceuticals (SNOA) Income from Discontinued Operations (2015 - 2020)
Sonoma Pharmaceuticals (SNOA) posted Income from Discontinued Operations of -$24000.0 for Q4 2020, up 22.58% on a QoQ basis from -$31000.0 in Q3 2020, and down 119.05% year-over-year from $126000.0 in Q1 2020.
Powered by 
Analysis
Sonoma Pharmaceuticals (SNOA) Income from Discontinued Operations (2015 - 2020) Analysis & Trends
Sonoma Pharmaceuticals has reported Income from Discontinued Operations for 5 years, with the latest figure at -$24000.0 in Q4 2020.
- On a quarterly basis, Income from Discontinued Operations fell 119.05% year-over-year to -$24000.0 in Q4 2020; TTM through Sep 2021 was -$24000.0, a 102.27% decrease from a year earlier, with the FY2021 full-year figure at $893000.0, up 236.98% from the prior year.
- Income from Discontinued Operations was -$24000.0 for Q4 2020 at Sonoma Pharmaceuticals, up from -$31000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $15.5 million in Q4 2016, with the low at -$31000.0 in Q3 2020.
- Average Income from Discontinued Operations over 4 years is $1.6 million, with a median of $309500.0 recorded in 2017.
- The largest YoY upside for Income from Discontinued Operations was 2214.63% in 2020 against a maximum downside of 136.47% in 2020.
- Over 4 years, Income from Discontinued Operations stood at $15.5 million in 2016, then sank by 96.81% to $493000.0 in 2017, then tumbled by 74.44% to $126000.0 in 2019, then slumped by 119.05% to -$24000.0 in 2020.
- The last three Income from Discontinued Operations figures came in at -$24000.0 (Q4 2020), -$31000.0 (Q3 2020), and $949000.0 (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.49 Bn | 48.62 Bn | 2.32 Bn | -74.00 Mn |
| 2 | Medline | 29.39 Bn | 26.71 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.03 Bn | 23.59 Bn | 329.20 Mn | - |
| 4 | Baxter International | 12.81 Bn | 10.66 Bn | 1.03 Bn | -9.00 Mn |
| 5 | Stevanato Group S.p.A | 5.52 Bn | 5.41 Bn | 100.91 Mn | - |
| 6 | Acme United | 233.44 Mn | 228.40 Mn | 26.69 Mn | - |
| 7 | Rockwell Medical | 31.09 Mn | 6.29 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | - |
| 9 | United Health Products | 8.37 Mn | 8.34 Mn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -24,000.00 |
| Sep 30, 2020 | -31,000.00 |
| Jun 30, 2020 | 949,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Dec 31, 2019 | 126,000.00 |
| Sep 30, 2019 | 85,000.00 |
| Jun 30, 2019 | 41,000.00 |
| Mar 31, 2017 | 493,000.00 |
| Dec 31, 2016 | 15.47 Mn |
| Sep 30, 2016 | 690,000.00 |
| Jun 30, 2016 | 619,000.00 |
| Mar 31, 2016 | 756,000.00 |
| Dec 31, 2015 | 1.07 Mn |